Page 148 - MEMOCiberesp014-ENG
P. 148
RESEARCH GROUPS
Nanobiotechnology
Programme: Nanomedicine / Biomaterials and Advanced Therapies
Lead Researcher: Villaverde Corrales, Antoni Group Members
STAFF MEMBERS: Corchero Nieto, Jose Luis | Garcia Fruitos, Elena | Mendoza Moreno, Rosa | Seras Franzoso, Joaquín
ASSOCIATED MEMBERS: Cubarsi Morera, Rafael | Ferrer Miralles, Neus | Pesarrodona Roches, Mireia | Vázquez Gómez, Esther | Vázquez Lima, Felicitas
CONTRIBUTORS: Cano Garrido, Olivia | Saccardo, Paolo | Zhikun, Xu Main lines of research
The team is co-ordinately acting to exploit microbial and non-microbial platforms for the production of new generation protein-based drugs, of interest in protein replacement therapies, gene therapy and regenerative medicine . In particular, we are interested in developing novel nanostructured materials in form of protein based drug delivery systems and of viral mimetics for the cell-targeted delivery of conventional drugs and nucleic acids . Associated activities are based in the improvement of biofabrication processes in different cell factories and in the use of non-protein nanomaterials such as magnetic particles .
148 CIBER-BBN » Annual report 2014
